In recent stock market developments, D. Boral Capital has reiterated its outlook on CytoSorbents (CTSO, Financial) with a "Buy" rating. The announcement, made by analyst Jason Kolbert, confirms that the financial advisory firm continues to support its previously established sentiment regarding the company's stock.
As of May 2, 2025, CytoSorbents (CTSO, Financial), a company listed on the NASDAQ exchange, maintains a price target of $10.00 USD. This target remains unchanged from the prior assessment, indicating steady confidence in the company's projected performance.
The analysis by D. Boral Capital outlines that the recommendation and price target for CTSO have not experienced any percentage change. This stable outlook suggests a consistent expectation of the stock's valuation and potential within the market.
Investors following CytoSorbents (CTSO, Financial) can reference the maintained "Buy" rating as an indication of the company's continued promise according to the insights provided by D. Boral Capital's analyst Jason Kolbert.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for CytoSorbents Corp (CTSO, Financial) is $7.00 with a high estimate of $10.00 and a low estimate of $4.00. The average target implies an upside of 593.07% from the current price of $1.01. More detailed estimate data can be found on the CytoSorbents Corp (CTSO) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, CytoSorbents Corp's (CTSO, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for CytoSorbents Corp (CTSO, Financial) in one year is $1.79, suggesting a upside of 77.23% from the current price of $1.01. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the CytoSorbents Corp (CTSO) Summary page.
